SyntekaBio Inc Capital Reinvestment Ratio
Latest as of December 2019:
0.06x
SyntekaBio Inc capital reinvestment ratio. SyntekaBio Inc (226330) has a Capital Reinvestment Ratio of 0.06x as of December 2019, meaning it reinvests 0% of its operating cash flow (₩15.10 Billion) in capital expenditures (₩924.66 Million). Check how aggressively does SyntekaBio Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
₩15.10 Billion
KRW
Capital Expenditures
₩924.66 Million
KRW
Data as of
Dec 2019
Most recent filing
SyntekaBio Inc Capital Reinvestment Ratio by Year (None–None)
SyntekaBio Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see how efficiently does SyntekaBio Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow